Akèy › Neuroblastom › Pennsylvania › Philadelphia

Etid klinik pou Neuroblastom nan Philadelphia, PA

9 etid pou Neuroblastom ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ap rekriteFaz 3

Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen

Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ap rekriteFaz 3

Children's Hospital of Philadelphia, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi lwen

365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2

Children's Hospital of Philadelphia, Philadelphia

12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2

Children's Hospital of Philedephia, Philadelphia

Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Ap rekriteFaz 1/2

Children's Hospital of Philadelphia, Philadelphia

Laj 1 a 30 · Tout sèks · Mizajou Jul 22, 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Ap rekriteFaz 2

Children's Hospital of Philadelphia, Philadelphia

Laj 1 a 31 · Tout sèks · Mizajou Jul 20, 2026 · NCT06450041

Neuroblastoma Biology Study

Ap rekriteEtid obsèvasyon

Children's Hospital of Philadelphia, Philadelphia

31 Days – 99 Years · Tout sèks · Mizajou Mar 23, 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Ap rekrite

Children's Hospital of Philadelphia, Philadelphia

Jiska laj 17 · Tout sèks · Mizajou Feb 10, 2026 · NCT06831552

Etid Neuroblastom nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.